HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rahul Ray Selected Research

1,25-dihydroxyvitamin D3-3-bromoacetate

10/2016PRL-3 engages the focal adhesion pathway in triple-negative breast cancer cells to alter actin structure and substrate adhesion properties critical for cell migration and invasion.
3/2016Genome-wide functional genetic screen with the anticancer agent AMPI-109 identifies PRL-3 as an oncogenic driver in triple-negative breast cancers.
6/2010Anti-growth effect of 1,25-dihydroxyvitamin D3-3-bromoacetate alone or in combination with 5-amino-imidazole-4-carboxamide-1-beta-4-ribofuranoside in pancreatic cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rahul Ray Research Topics

Disease

9Neoplasms (Cancer)
03/2012 - 10/2002
6Breast Neoplasms (Breast Cancer)
08/2011 - 10/2002
4Prostatic Neoplasms (Prostate Cancer)
06/2010 - 08/2003
2Pancreatic Neoplasms (Pancreatic Cancer)
06/2010 - 01/2003
1Alopecia (Baldness)
07/2021
1Rheumatoid Arthritis
01/2021
1Neoplasm Metastasis (Metastasis)
10/2016
1Triple Negative Breast Neoplasms
03/2016
1Disease Progression
03/2016
1Ulcer
09/2015
1Cicatrix (Scar)
09/2015
1Livedoid Vasculopathy
09/2015
1Hyperhomocysteinemia
09/2015
1Psoriasis (Pustulosis Palmaris et Plantaris)
11/2013
1Arthritis (Polyarthritis)
11/2013
1Kidney Neoplasms (Kidney Cancer)
12/2010
1Residual Neoplasm
10/2006
1Carcinogenesis
01/2003

Drug/Important Bio-Agent (IBA)

5Hormones (Hormone)IBA
08/2011 - 10/2002
5Estrogen ReceptorsIBA
08/2011 - 10/2002
4Vitamin DFDA LinkGeneric
03/2012 - 01/2003
4PorphyrinsIBA
08/2011 - 10/2002
4Estrogens (Estrogen)FDA Link
08/2011 - 10/2002
31,25-dihydroxyvitamin D3-3-bromoacetateIBA
10/2016 - 06/2010
3AndrogensIBA
03/2012 - 12/2004
3Calcitriol Receptors (Calcitriol Receptor)IBA
12/2010 - 01/2003
31,25-dihydroxyvitamin DIBA
09/2007 - 08/2003
2hydroxide ionIBA
12/2010 - 01/2003
2Calcifediol (Calcidiol)FDA Link
09/2007 - 12/2004
1Minoxidil (Rogaine)FDA LinkGeneric
07/2021
1Adenosine DeaminaseIBA
01/2021
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
10/2016
1Antineoplastic Agents (Antineoplastics)IBA
03/2016
1Adrenal Cortex Hormones (Corticosteroids)IBA
09/2015
1Dental Porcelain (Porcelain)IBA
09/2015
15-(6)-carboxyfluorescein diacetate succinimidyl ester (CFSE)IBA
11/2013
1Annexin A5IBA
11/2013
1CalciumIBA
03/2012
1Therapeutic UsesIBA
12/2010
1Cyclin AIBA
12/2010
1AICA ribonucleotide (ZMP)IBA
06/2010
1Pharmaceutical PreparationsIBA
10/2006
11-phenyl-3,3-dimethyltriazene (PDT)IBA
10/2006
1tamoxifen-pyropheophorbide conjugateIBA
10/2006
1TamoxifenFDA LinkGeneric
10/2006
1Photosensitizing Agents (Photosensitizers)IBA
10/2006
1Estrogen Receptor Modulators (Antiestrogen)IBA
10/2006
1CaspasesIBA
12/2004
1vitamin D-binding protein-macrophage activating factorIBA
01/2003
1Cholecalciferol (Vitamin D3)FDA Link
01/2003
1Differentiation AntigensIBA
01/2003
11-hydroxyvitamin D5IBA
01/2003
1Vitamin D-Binding ProteinIBA
01/2003
1Estradiol (Delestrogen)FDA LinkGeneric
10/2002
1tetraphenylporphyrinIBA
10/2002
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
10/2002

Therapy/Procedure

3Therapeutics
09/2015 - 01/2003
3Photochemotherapy (Photodynamic Therapy)
10/2006 - 10/2002
1Hyperbaric Oxygenation
09/2015